Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Neuropharmacology
|
January 1, 1996
The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors
A Boireau, F Bordier, G Durand, et al.
Neuroscience Letters
|
July 28, 1995
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission
A Boireau, F Bordier, P Dubédat, et al.
European Journal of Pharmacology
|
August 5, 2000
Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro
A Boireau, C Monterrat, F Bordier, et al.
Neuropharmacology
|
March 23, 2000
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation
A Boireau, P Dubedat, F Bordier, et al.
Neuroscience Letters
|
November 19, 1997
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice
A Boireau, F Bordier, P Dubédat, et al.
Annales De Dermatologie Et De Venereologie
|
May 7, 2008
[Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases]
F Bordier-Lamy, J-P Palot, F Vitry, et al.
Annals of the New York Academy of Sciences
|
February 15, 2000
Effects of ebselen, a glutathione peroxidase mimic, in several models of mitochondrial dysfunction
A Boireau, P Dubedat, F Bordier, et al.
Annales De Dermatologie Et De Venereologie
|
June 30, 2009
[Epidermolysis bullosa acquisita of childhood]
F Bordier-Lamy, C Eschard, M Coste, et al.
Toxicologic Pathology
|
October 24, 2018
Specificities of the Skin Morphology in Juvenile Minipigs
Béatrice E Gauthier, Laure Penard, Nicole F Bordier, et al.
Neuroreport
|
December 20, 1994
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice
A Boireau, P Dubédat, F Bordier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Neuropharmacology
|
January 1, 1996
The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors
A Boireau, F Bordier, G Durand, et al.
Neuroscience Letters
|
July 28, 1995
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission
A Boireau, F Bordier, P Dubédat, et al.
European Journal of Pharmacology
|
August 5, 2000
Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro
A Boireau, C Monterrat, F Bordier, et al.
Neuropharmacology
|
March 23, 2000
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation
A Boireau, P Dubedat, F Bordier, et al.
Neuroscience Letters
|
November 19, 1997
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice
A Boireau, F Bordier, P Dubédat, et al.
Annales De Dermatologie Et De Venereologie
|
May 7, 2008
[Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases]
F Bordier-Lamy, J-P Palot, F Vitry, et al.
Annals of the New York Academy of Sciences
|
February 15, 2000
Effects of ebselen, a glutathione peroxidase mimic, in several models of mitochondrial dysfunction
A Boireau, P Dubedat, F Bordier, et al.
Annales De Dermatologie Et De Venereologie
|
June 30, 2009
[Epidermolysis bullosa acquisita of childhood]
F Bordier-Lamy, C Eschard, M Coste, et al.
Toxicologic Pathology
|
October 24, 2018
Specificities of the Skin Morphology in Juvenile Minipigs
Béatrice E Gauthier, Laure Penard, Nicole F Bordier, et al.
Neuroreport
|
December 20, 1994
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice
A Boireau, P Dubédat, F Bordier, et al.
Page
of 2